Coronary-artery stenting compared with balloon angioplasty for restenosis after initial balloon angioplasty

被引:223
作者
Erbel, R
Haude, M
Höpp, HW
Franzen, D
Rupprecht, HJ
Heublein, B
Fischer, K
De Jaegere, P
Serruys, P
Rutsch, W
Probst, P
机构
[1] Univ Essen Gesamthsch, Dept Cardiol, D-45122 Essen, Germany
[2] Univ Cologne, Dept Med 3, Cologne, Germany
[3] Johannes Gutenberg Univ Mainz, Med Clin 2, D-6500 Mainz, Germany
[4] Hannover Med Sch, Dept Cardiothorac Surg, D-3000 Hannover, Germany
[5] Erasmus Univ, Ctr Thorax, Dept Cardiol, NL-3000 DR Rotterdam, Netherlands
[6] Univ Clin Charite, Dept Cardiol, Berlin, Germany
[7] Univ Vienna, Dept Cardiol, Vienna, Austria
关键词
D O I
10.1056/NEJM199812033392304
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Intracoronary stenting reduces the rate of restenosis after angioplasty in patients with new coronary lesions. We conducted a prospective, randomized, multicenter study to determine whether intracoronary stenting, as compared with standard balloon angioplasty, reduces the recurrence of luminal narrowing in restenotic lesions. Method; A total of 383 patients who had undergone at least one balloon angioplasty and who had clinical and angiographic evidence of restenosis after the procedure were randomly assigned to undergo standard balloon angioplasty (192 patients) or intracoronary stenting with a Palmaz-Schatz stent (191 patients). The primary end point was angiographic evidence of restenosis (defined as stenosis of more than 50 percent of the luminal diameter) at six months. The secondary end points were death, Q-wave myocardial infarction, bypass surgery, and revascularization of the target vessel. Results The rate of restenosis was significantly higher in the angioplasty group than in the stent group (32 percent as compared with 18 percent, P = 0.03). Revascularization of the target vessel at six months was required in 27 percent of the angioplasty group but in only 10 percent of the stent group (P = 0.001). This difference resulted from a smaller mean (+/-SD) minimal luminal diameter in the angioplasty group (1.85+/-0.56 mm) than in the stent group (2.04+/-0.66 mm), with a mean difference of 0.19 mm (P = 0.01) at follow-up. Subacute thrombosis occurred in 0.6 percent of the angioplasty group and in 3.9 percent of the stent group. The rate of event-free survival at 250 days was 72 percent in the angioplasty group and 84 percent in the stent group (P = 0.04). Conclusions Elective coronary stenting was effective in the treatment of restenosis after balloon angioplasty. Stenting resulted in a lower rate of recurrent stenosis despite a higher incidence of subacute thrombosis. (N Engl J Med 1998;339:1672-8,) (C)1998, Massachusetts Medical Society.
引用
收藏
页码:1672 / 1678
页数:7
相关论文
共 38 条
[1]   CLINICAL CHARACTERISTICS AND ANGIOGRAPHIC FOLLOW-UP OF PATIENTS UNDERGOING EARLY OR LATE REPEAT DILATION FOR A 1ST RESTENOSIS [J].
BAUTERS, C ;
LABLANCHE, JM ;
MCFADDEN, EP ;
LEROY, F ;
BERTRAND, ME .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1992, 20 (04) :845-848
[2]   CLINICAL, PHYSIOLOGICAL, ANATOMIC AND PROCEDURAL FACTORS PREDICTIVE OF RESTENOSIS AFTER PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY [J].
BOURASSA, MG ;
LESPERANCE, J ;
EASTWOOD, C ;
SCHWARTZ, L ;
COTE, G ;
KAZIM, F ;
HUDON, G .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1991, 18 (02) :368-376
[3]   Results of coronary stenting for restenosis [J].
Colombo, A ;
Ferraro, M ;
Itoh, A ;
Martini, G ;
Blengino, S ;
Finci, L .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1996, 28 (04) :830-836
[4]   INTRACORONARY STENTING WITHOUT ANTICOAGULATION ACCOMPLISHED WITH INTRAVASCULAR ULTRASOUND GUIDANCE [J].
COLOMBO, A ;
HALL, P ;
NAKAMURA, S ;
ALMAGOR, Y ;
MAIELLO, L ;
MARTINI, G ;
GAGLIONE, A ;
GOLDBERG, SL ;
TOBIS, JM .
CIRCULATION, 1995, 91 (06) :1676-1688
[5]   RESTENOSIS AFTER PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY - HAVE WE BEEN AIMING AT THE WRONG TARGET [J].
CURRIER, JW ;
FAXON, DP .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1995, 25 (02) :516-520
[6]  
Debbas NMG, 1996, J INVASIVE CARDIOL, V8, P241
[7]   ONE-YEAR FOLLOW-UP RESULTS OF THE 1985-1986 NATIONAL-HEART-LUNG-AND-BLOOD-INSTITUTES PERCUTANEOUS TRANS-LUMINAL CORONARY ANGIOPLASTY REGISTRY [J].
DETRE, K ;
HOLUBKOV, R ;
KELSEY, S ;
BOURASSA, M ;
WILLIAMS, D ;
HOLMES, D ;
DORROS, G ;
FAXON, D ;
MYLER, R ;
KENT, K ;
COWLEY, M ;
CANNON, R ;
ROBERTSON, T .
CIRCULATION, 1989, 80 (03) :421-428
[8]   RESTENOSIS AFTER PLACEMENT OF PALMAZ-SCHATZ STENTS IN NATIVE CORONARY-ARTERIES - INITIAL RESULTS OF A MULTICENTER EXPERIENCE [J].
ELLIS, SG ;
SAVAGE, M ;
FISCHMAN, D ;
BAIM, DS ;
LEON, M ;
GOLDBERG, S ;
HIRSHFELD, JW ;
CLEMAN, MW ;
TEIRSTEIN, PS ;
WALKER, C ;
BAILEY, S ;
BUCHBINDER, M ;
TOPOL, EJ ;
SCHATZ, RA .
CIRCULATION, 1992, 86 (06) :1836-1844
[9]  
ERBEL R, 1989, Z KARDIOL, V78, P71
[10]   EFFECT OF ANTIPLATELET THERAPY ON RESTENOSIS AFTER EXPERIMENTAL ANGIOPLASTY [J].
FAXON, DP ;
SANBORN, TA ;
HAUDENSCHILD, CC ;
RYAN, TJ .
AMERICAN JOURNAL OF CARDIOLOGY, 1984, 53 (12) :C72-C76